Mechanisms involved in MDR include overexpression of multispecific ATP-dependent drug efflux pumps, such as P-gp (MDR1, ABCB1), MRP1, and BCRP (ABCG2), that reduce the concentration of the drug available for cancer cells [6]. Here, PGP is linked to cancer.